46 related articles for article (PubMed ID: 10840429)
1. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.
Ruseckaite R; Beckmann K; O'Callaghan M; Roder D; Moretti K; Millar J; Evans S
BMC Cancer; 2016 Aug; 16():607. PubMed ID: 27496055
[TBL] [Abstract][Full Text] [Related]
2. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
Cooperberg MR; Lubeck DP; Meng MV; Mehta SS; Carroll PR
J Clin Oncol; 2004 Jun; 22(11):2141-9. PubMed ID: 15169800
[TBL] [Abstract][Full Text] [Related]
3. Updated trends in imaging use in men diagnosed with prostate cancer.
Porten SP; Smith A; Odisho AY; Litwin MS; Saigal CS; Carroll PR; Cooperberg MR;
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):246-51. PubMed ID: 24819235
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer.
Hu JC; Tosoian JJ; Qi J; Kaye D; Johnson A; Linsell S; Montie JE; Ghani KR; Miller DC; Wojno K; Burks FN; Spratt DE; Morgan TM
JCO Precis Oncol; 2018; 2():. PubMed ID: 32832833
[TBL] [Abstract][Full Text] [Related]
5. Ten-year work burden after prostate cancer treatment.
Washington SL; Lonergan PE; Cowan JE; Zhao S; Broering JM; Palmer NR; Hicks C; Cooperberg MR; Carroll PR
Cancer Med; 2023 Sep; 12(18):19234-19244. PubMed ID: 37724617
[TBL] [Abstract][Full Text] [Related]
6. A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.
Leapman MS; Loeb S; Cooperberg MR; Catalona WJ; Gaylis FD
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 37101361
[No Abstract] [Full Text] [Related]
7. Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.
Kasperzyk JL; Shappley WV; Kenfield SA; Mucci LA; Kurth T; Ma J; Stampfer MJ; Sanda MG
J Urol; 2011 Nov; 186(5):1862-7. PubMed ID: 21944095
[TBL] [Abstract][Full Text] [Related]
8. When 'dueling technologies' are mistaken for progress.
Logothetis CJ
BJU Int; 2011 Jun; 107(11):1699-700. PubMed ID: 21592278
[No Abstract] [Full Text] [Related]
9. Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.
Shappley WV; Kenfield SA; Kasperzyk JL; Qiu W; Stampfer MJ; Sanda MG; Chan JM
J Clin Oncol; 2009 Oct; 27(30):4980-5. PubMed ID: 19720918
[TBL] [Abstract][Full Text] [Related]
10. Incompetent patients, substitute decision making, and quality of life: some ethical considerations.
Kluge EH
Medscape J Med; 2008; 10(10):237. PubMed ID: 19099031
[TBL] [Abstract][Full Text] [Related]
11. Managing the low-socioeconomic-status prostate cancer patient.
Rayford W
J Natl Med Assoc; 2006 Apr; 98(4):521-30. PubMed ID: 16623064
[TBL] [Abstract][Full Text] [Related]
12. Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation.
Kennedy L; Craig AM
Pharmacoeconomics; 2004; 22(9):551-68. PubMed ID: 15209525
[TBL] [Abstract][Full Text] [Related]
13. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
Cooperberg MR; Broering JM; Latini DM; Litwin MS; Wallace KL; Carroll PR
Curr Urol Rep; 2004 Jun; 5(3):166-72. PubMed ID: 15161564
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer management: (1) an update on localised disease.
Bott SR; Birtle AJ; Taylor CJ; Kirby RS
Postgrad Med J; 2003 Oct; 79(936):575-80. PubMed ID: 14612600
[TBL] [Abstract][Full Text] [Related]
15. National practice patterns and time trends in androgen ablation for localized prostate cancer.
Cooperberg MR; Grossfeld GD; Lubeck DP; Carroll PR
J Natl Cancer Inst; 2003 Jul; 95(13):981-9. PubMed ID: 12837834
[TBL] [Abstract][Full Text] [Related]
16. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
Koppie TM; Grossfeld GD; Miller D; Yu J; Stier D; Broering JM; Lubeck D; Henning JM; Flanders SC; Carroll PR
J Urol; 2000 Jul; 164(1):81-8. PubMed ID: 10840429
[TBL] [Abstract][Full Text] [Related]
17. Watchful waiting and factors predictive of secondary treatment of localized prostate cancer.
Wu H; Sun L; Moul JW; Wu HY; McLeod DG; Amling C; Lance R; Kusuda L; Donahue T; Foley J; Chung A; Sexton W; Soderdahl D
J Urol; 2004 Mar; 171(3):1111-6. PubMed ID: 14767282
[TBL] [Abstract][Full Text] [Related]
18. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.
Meng MV; Elkin EP; Harlan SR; Mehta SS; Lubeck DP; Carroll PR
J Urol; 2003 Dec; 170(6 Pt 1):2279-83. PubMed ID: 14634396
[TBL] [Abstract][Full Text] [Related]
19. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
